Market Cap 46.83M
Revenue (ttm) 590,000.00
Net Income (ttm) -2.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -405.08%
Debt to Equity Ratio 0.00
Volume 2,200
Avg Vol 12,014
Day's Range N/A - N/A
Shares Out 31.41M
Stochastic %K 32%
Beta 0.45
Analysts Strong Buy
Price Target $0.04

Company Profile

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Industry: Medical Devices
Sector: Healthcare
Phone: 317 576 0183
Address:
1777 Maryland Avenue, Niagara Falls, United States
SkylineCCG
SkylineCCG May. 29 at 3:15 PM
Positron Corporation (OTC: $POSC) Expands Its Imaging Footprint Positron Corporation continues to gain traction in the molecular imaging space with the recent sale of its NeuSight PET-CT 64-slice scanner to a leading nuclear cardiologist focused on cardiovascular diagnostics and interventional care. The NeuSight PET-CT system is engineered for precision and performance—designed with a compact footprint, 72 cm gantry for patient comfort, and high-sensitivity imaging that reduces radiation exposure for both patients and staff. As healthcare providers seek smarter, space-conscious solutions, Positron’s platform offers a powerful edge for nuclear cardiology and molecular imaging environments nationwide. #MedicalImaging #MolecularImaging #CardiacPET #HealthcareTech #PETCTScanner #NuclearCardiology #SkylineClients #Positron #InvestorRelations Skyline is paid by $POSC for IR services. Disclaimer 17(b): https://skylineccg.com/disclosures/
0 · Reply
RunZeke
RunZeke May. 29 at 2:29 PM
$POSC https://www.positron.com/press-release?webmasterId=130005&storyId=6320363803024431
0 · Reply
SkylineCCG
SkylineCCG Apr. 14 at 4:37 PM
Positron Corporation (OTC: $POSC) has announced an agreement to sell four of its PET-CT scanners to a respected leader in cardiovascular diagnostics and treatment. As a molecular imaging medical device company specializing in PET and PET-CT imaging systems, Positron continues to strengthen its position in the cardiac imaging market by delivering advanced technology designed to improve diagnostic precision, workflow efficiency, and patient outcomes. This milestone highlights the increasing demand for cardiac PET imaging and our client's ability to meet the clinical and operational needs of healthcare providers nationwide. Check out the full press release here: https://www.globenewswire.com/news-release/2025/04/14/3061028/0/en/Positron-Corporation-Secures-Agreement-to-Sell-Four-PET-CT-Scanners.html #SkylineCCG #Positron #MolecularImaging #CardiacImaging #PETCT #HealthcareInnovation #MedicalDevices #ImagingSolutions #Cardiology #DiagnosticImaging Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Mar. 31 at 8:56 PM
Positron Corporation (OTC: $POSC) has secured $8 million in capital to fast-track growth and expand its footprint in the PET-CT imaging market. This equity-based investment fuels Positron’s momentum as a leading force in molecular imaging, powering initiatives across sales, marketing, product development, and global market expansion. It also lays the groundwork for a return to SEC filings and a future uplisting to a senior exchange. Congratulations to our client, read the full release here: https://www.globenewswire.com/news-release/2025/03/31/3052732/0/en/Positron-Corporation-Secures-8-Million-in-Capital-to-Accelerate-Growth-and-Market-Expansion.html #MolecularImaging #Cardiology #PETSCAN #MedTech #PETCT #InvestorNews #SkylineCCG #CapitalMarkets #MedTech #Investors Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Feb. 28 at 2:26 PM
Our client, Positron Corporation (OTC: $POSC) is revolutionizing cardiac imaging with the NeuSight™ PET-CT. The NeuSight™ PET-CT is designed to optimize imaging needs with advanced capabilities at an exceptional cost, bringing unmatched value to cardiac PET-CT imaging including: 🧠 Intelligent Software 📸 Exceptional Image Quality 🔬 Precision Craftsmanship As the demand for cutting-edge nuclear cardiology solutions grows, Positron is at the forefront, seamlessly integrating innovation and efficiency to enhance patient care and diagnostic accuracy. 🔗 Discover how NeuSight™ PET-CT is shaping the future of nuclear cardiology: https://www.positron.com/ #Positron #NeuSightPETCT #NuclearCardiology #PETCT #ImagingInnovation #SkylineCCG Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
RealAvidTrader
RealAvidTrader Feb. 12 at 5:52 PM
🤷‍♂️I TOLD YOU THIS STOCK WAS A GUARANTEED DOUBLE🤷‍♂️ DO NOT FADE ME! $POSC $PRTT $EBFI https://youtu.be/f-h8WR5dBDI
1 · Reply
RealAvidTrader
RealAvidTrader Feb. 11 at 10:29 PM
$POSC HOPE YOU LISTENED This Penny Stock is a GUARANTEED Double!! https://youtu.be/Yx6wZNz95dM
0 · Reply
Stockmesg
Stockmesg Feb. 11 at 7:04 PM
$POSC 2.25 is next resistance
1 · Reply
SkylineCCG
SkylineCCG Jan. 24 at 5:39 PM
Positron Corporation (OTC: $POSC), a trailblazer in molecular imaging, has secured an agreement to sell and rent eight NeuSight PET-CT 64-slice scanners to a leading provider of advanced cardiovascular diagnostics and treatment. This achievement underscores Positron’s commitment to delivering cutting-edge imaging solutions that empower healthcare providers to elevate patient care and achieve exceptional clinical outcomes. Designed to support both cardiology and oncology clinical studies, the NeuSight PET-CT continues to transform the landscape of molecular imaging, offering precision, versatility, and cost-effectiveness. Read the press release here: https://www.manilatimes.net/2025/01/24/tmt-newswire/globenewswire/positron-corporation-secures-agreement-to-sell-and-rent-eight-neusight-pet-ct-scanners/2044262 Disclaimer 17(b): Skyline is paid by $POSC for IR services. https://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Jan. 13 at 8:21 PM
Positron Corporation (OTC: $POSC), a leader in molecular imaging medical devices, has engaged Skyline Corporate Communications Group, LLC to enhance its investor relations and corporate communications efforts within the financial community. Positron’s advancements in PET and PET-CT imaging systems and its ambitious growth objectives have positioned the Company at an exciting juncture as it transitions into its commercialization phase. As Positron’s investor relations partner, Skyline will leverage its proven methodologies and extensive market experience to ensure the Company’s innovative solutions and strategic milestones are effectively communicated to the investing public. We are honored to support Positron in amplifying its corporate message and advancing its presence in the medical imaging market. Skyline is paid by $POSC for IR services. Disclaimer 17(b): https://skylineccg.com/disclosures/
0 · Reply
Latest News on POSC
No data available.
SkylineCCG
SkylineCCG May. 29 at 3:15 PM
Positron Corporation (OTC: $POSC) Expands Its Imaging Footprint Positron Corporation continues to gain traction in the molecular imaging space with the recent sale of its NeuSight PET-CT 64-slice scanner to a leading nuclear cardiologist focused on cardiovascular diagnostics and interventional care. The NeuSight PET-CT system is engineered for precision and performance—designed with a compact footprint, 72 cm gantry for patient comfort, and high-sensitivity imaging that reduces radiation exposure for both patients and staff. As healthcare providers seek smarter, space-conscious solutions, Positron’s platform offers a powerful edge for nuclear cardiology and molecular imaging environments nationwide. #MedicalImaging #MolecularImaging #CardiacPET #HealthcareTech #PETCTScanner #NuclearCardiology #SkylineClients #Positron #InvestorRelations Skyline is paid by $POSC for IR services. Disclaimer 17(b): https://skylineccg.com/disclosures/
0 · Reply
RunZeke
RunZeke May. 29 at 2:29 PM
$POSC https://www.positron.com/press-release?webmasterId=130005&storyId=6320363803024431
0 · Reply
SkylineCCG
SkylineCCG Apr. 14 at 4:37 PM
Positron Corporation (OTC: $POSC) has announced an agreement to sell four of its PET-CT scanners to a respected leader in cardiovascular diagnostics and treatment. As a molecular imaging medical device company specializing in PET and PET-CT imaging systems, Positron continues to strengthen its position in the cardiac imaging market by delivering advanced technology designed to improve diagnostic precision, workflow efficiency, and patient outcomes. This milestone highlights the increasing demand for cardiac PET imaging and our client's ability to meet the clinical and operational needs of healthcare providers nationwide. Check out the full press release here: https://www.globenewswire.com/news-release/2025/04/14/3061028/0/en/Positron-Corporation-Secures-Agreement-to-Sell-Four-PET-CT-Scanners.html #SkylineCCG #Positron #MolecularImaging #CardiacImaging #PETCT #HealthcareInnovation #MedicalDevices #ImagingSolutions #Cardiology #DiagnosticImaging Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Mar. 31 at 8:56 PM
Positron Corporation (OTC: $POSC) has secured $8 million in capital to fast-track growth and expand its footprint in the PET-CT imaging market. This equity-based investment fuels Positron’s momentum as a leading force in molecular imaging, powering initiatives across sales, marketing, product development, and global market expansion. It also lays the groundwork for a return to SEC filings and a future uplisting to a senior exchange. Congratulations to our client, read the full release here: https://www.globenewswire.com/news-release/2025/03/31/3052732/0/en/Positron-Corporation-Secures-8-Million-in-Capital-to-Accelerate-Growth-and-Market-Expansion.html #MolecularImaging #Cardiology #PETSCAN #MedTech #PETCT #InvestorNews #SkylineCCG #CapitalMarkets #MedTech #Investors Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Feb. 28 at 2:26 PM
Our client, Positron Corporation (OTC: $POSC) is revolutionizing cardiac imaging with the NeuSight™ PET-CT. The NeuSight™ PET-CT is designed to optimize imaging needs with advanced capabilities at an exceptional cost, bringing unmatched value to cardiac PET-CT imaging including: 🧠 Intelligent Software 📸 Exceptional Image Quality 🔬 Precision Craftsmanship As the demand for cutting-edge nuclear cardiology solutions grows, Positron is at the forefront, seamlessly integrating innovation and efficiency to enhance patient care and diagnostic accuracy. 🔗 Discover how NeuSight™ PET-CT is shaping the future of nuclear cardiology: https://www.positron.com/ #Positron #NeuSightPETCT #NuclearCardiology #PETCT #ImagingInnovation #SkylineCCG Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
RealAvidTrader
RealAvidTrader Feb. 12 at 5:52 PM
🤷‍♂️I TOLD YOU THIS STOCK WAS A GUARANTEED DOUBLE🤷‍♂️ DO NOT FADE ME! $POSC $PRTT $EBFI https://youtu.be/f-h8WR5dBDI
1 · Reply
RealAvidTrader
RealAvidTrader Feb. 11 at 10:29 PM
$POSC HOPE YOU LISTENED This Penny Stock is a GUARANTEED Double!! https://youtu.be/Yx6wZNz95dM
0 · Reply
Stockmesg
Stockmesg Feb. 11 at 7:04 PM
$POSC 2.25 is next resistance
1 · Reply
SkylineCCG
SkylineCCG Jan. 24 at 5:39 PM
Positron Corporation (OTC: $POSC), a trailblazer in molecular imaging, has secured an agreement to sell and rent eight NeuSight PET-CT 64-slice scanners to a leading provider of advanced cardiovascular diagnostics and treatment. This achievement underscores Positron’s commitment to delivering cutting-edge imaging solutions that empower healthcare providers to elevate patient care and achieve exceptional clinical outcomes. Designed to support both cardiology and oncology clinical studies, the NeuSight PET-CT continues to transform the landscape of molecular imaging, offering precision, versatility, and cost-effectiveness. Read the press release here: https://www.manilatimes.net/2025/01/24/tmt-newswire/globenewswire/positron-corporation-secures-agreement-to-sell-and-rent-eight-neusight-pet-ct-scanners/2044262 Disclaimer 17(b): Skyline is paid by $POSC for IR services. https://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Jan. 13 at 8:21 PM
Positron Corporation (OTC: $POSC), a leader in molecular imaging medical devices, has engaged Skyline Corporate Communications Group, LLC to enhance its investor relations and corporate communications efforts within the financial community. Positron’s advancements in PET and PET-CT imaging systems and its ambitious growth objectives have positioned the Company at an exciting juncture as it transitions into its commercialization phase. As Positron’s investor relations partner, Skyline will leverage its proven methodologies and extensive market experience to ensure the Company’s innovative solutions and strategic milestones are effectively communicated to the investing public. We are honored to support Positron in amplifying its corporate message and advancing its presence in the medical imaging market. Skyline is paid by $POSC for IR services. Disclaimer 17(b): https://skylineccg.com/disclosures/
0 · Reply
LewisDaKat
LewisDaKat Dec. 13 at 9:25 PM
News out $POSC Expected US Company Earnings on Friday, December 13th, 2024 https://marketwirenews.com/news-releases/expected-us-company-earnings-on-friday-december-13th-5268467507494000.html $POSC
0 · Reply
RealAvidTrader
RealAvidTrader Apr. 18 at 2:32 AM
0 · Reply
RealAvidTrader
RealAvidTrader Feb. 26 at 4:34 PM
$CRDL $PRTT $POSC The ULTIMATE Guide to Finding Hidden Gem Stocks | AvidTrader https://youtu.be/pZAKJLk9o0I
0 · Reply
EarningsInsider
EarningsInsider Jan. 25 at 2:45 PM
Positron Sees Short Interest Decrease from 300 shares to 100 shares. $POSC https://www.marketbeat.com/stocks/OTCMKTS/POSC/short-interest/
0 · Reply
Stock_Titan
Stock_Titan Nov. 24 at 3:00 PM
$POSC Positron Corporation Announces Attrius® PET System Sale Article Available on StockTitan Website.
0 · Reply
RealAvidTrader
RealAvidTrader Oct. 17 at 8:12 PM
$POSC $OSIS $GEHC $LNTH FDA APPROVAL CAN SEND THIS PENNY STOCK SOARING! https://youtu.be/42AI9djkN0s
0 · Reply
Stock_Titan
Stock_Titan Oct. 4 at 2:48 PM
$POSC Positron Corporation Announces Attrius® PET System Sale https://www.stocktitan.net/news/POSC/positron-corporation-announces-attrius-r-pet-system-43ybryt23oqt.html
0 · Reply
Stock_Titan
Stock_Titan Sep. 8 at 12:00 PM
$POSC Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device https://www.stocktitan.net/news/POSC/positron-corporation-announces-start-of-clinical-study-of-affinity-6gxtdh2glbo8.html
0 · Reply
Stock_Titan
Stock_Titan Jul. 31 at 12:00 PM
$POSC Positron Corporation Orders Six Attrius® PET Systems and Components from Neusoft Positron Medical Systems https://www.stocktitan.net/news/POSC/positron-corporation-orders-six-attrius-r-pet-systems-and-components-gewiggmsk9et.html
0 · Reply